Per Stirling Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-720
| Closed | -$457K | – | 286 |
|
|
2025
Q1 | $457K | Hold |
720
| – | – | 0.07% | 173 |
|
|
2024
Q4 | $513K | Sell |
720
-3
| -0.4% | -$2.14K | 0.07% | 159 |
|
|
2024
Q3 | $760K | Sell |
723
-7
| -1% | -$7.36K | 0.11% | 134 |
|
|
2024
Q2 | $767K | Hold |
730
| – | – | 0.12% | 118 |
|
|
2024
Q1 | $702K | Hold |
730
| – | – | 0.12% | 114 |
|
|
2023
Q4 | $641K | Hold |
730
| – | – | 0.12% | 107 |
|
|
2023
Q3 | $600K | Sell |
730
-5
| -0.7% | -$4.11K | 0.12% | 105 |
|
|
2023
Q2 | $528K | Sell |
735
-28
| -4% | -$20.1K | 0.11% | 116 |
|
|
2023
Q1 | $627K | Sell |
763
-150
| -16% | -$123K | 0.14% | 93 |
|
|
2022
Q4 | $659K | Buy |
+913
| New | +$659K | 0.12% | 103 |
|